Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

STRATATECH CORPORATION

UEI: WE88ZJ5AY3F9CAGE: 46WA2

STRATATECH CORPORATION is a federal contractor, registered under UEI WE88ZJ5AY3F9 and CAGE code 46WA2. It has been awarded $120,839,456 in federal contracts. Primary work spans Research and Development in Biotechnology, Unknown NAICS, and Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). Top awarding agencies include Department Of Health And Human Services, Department Of Defense, and Department Of Defense (dod).

Contact Information

Registration and classification details

Registration

UEI Code

WE88ZJ5AY3F9

CAGE Code

46WA2

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationForeign Owned

NAICS Codes

325413In-Vitro Diagnostic Substance Manufacturing
325414Biological Product (except Diagnostic) Manufacturing(Primary)
541714Research and Development in Biotechnology (except Nanobiotechnology)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Stratatech Corporation specializes in biotechnology research and pharmaceutical manufacturing, with a focus on advanced cellular therapies and regulated production processes. Their core capabilities include the development of cell-based skin substitutes for definitive burn care, leveraging tissue en...

Stratatech Corporation specializes in biotechnology research and pharmaceutical manufacturing, with a focus on advanced cellular therapies and regulated production processes. Their core capabilities include the development of cell-based skin substitutes for definitive burn care, leveraging tissue engineering and regenerative medicine methodologies. The company demonstrates expertise in navigating complex regulatory frameworks for biologics, including compliance with federal procurement standards and contract closeout procedures under FAR guidelines. Technical proficiency spans laboratory-scale bioprocessing, quality control protocols for therapeutic products, and the transition of experimental biotech innovations toward operational readiness. Their work reflects a strong understanding of Good Manufacturing Practices (GMP) and the lifecycle management of federally funded biomedical research initiatives. Stratatech has delivered services primarily for the Department of Health and Human Services and the Department of Veterans Affairs. For HHS, they have supported high-priority biomedical R&D projects involving novel regenerative therapies, while their engagement with the VA involved pharmaceutical manufacturing activities, including contract administration and termination actions consistent with federal acquisition policy. Their relationship with these agencies centers on mission-critical health innovation programs requiring precise technical execution and strict adherence to federal compliance standards. The company’s primary industry focus lies in Research and Development in Biotechnology (NAICS 541711) and Pharmaceutical Preparation Manufacturing (NAICS 325412), positioning them at the intersection of early-stage biomedical innovation and controlled production environments. They specialize in translating laboratory discoveries into viable medical countermeasures, particularly in trauma care and regenerative applications, serving niche segments within federal health research and therapeutic manufacturing markets. Stratatech Corporation is a small business structured as a 2L entity, headquartered in Hazelwood, Missouri. While currently holding no formal government certifications, their operational focus and contract history indicate a disciplined approach to federal compliance and technical execution within highly regulated biomedical domains.

Key Performance Metrics

Awards Count

26

All time

Active

0

Currently performing

Completed

26

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
Awards by Agency Over Time
Awards by Place of Performance

Compete with STRATATECH CORPORATION

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for STRATATECH CORPORATION

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in STRATATECH CORPORATION's top NAICS codes and agencies

NAICS: 541330
New
Federal
AIR FORCE CRYPTOLOGIC OFFICE COMMERCIAL SOLUTIONS OPENING
Solicitation # FA7037-21-S-C001
The Air Force Cryptologic Office (AFCO) Cyberspace Intelligence Surveillance and Reconnaissance and Multi-Domain Innovation Division is soliciting innovative commercial capabilities through Commercial Solutions Opening FA7037-21-S-C001. The agency is seeking mature technologies and innovative services in Electromagnetic Warfare, Information Operations, and electromagnetic digital communications, with a specific goal of achieving a field demonstration within one year. The procurement process is divided into two phases: Phase I requires the submission of a quad chart and a white paper, while Phase II consists of full proposals by invitation only. Awards may be issued as traditional contracts or Other Transactions (OT), with potential funding ranging from 50,000 dollars to 50 million dollars over a period of performance lasting between one and five years. The evaluation process is based on technical merit, importance to agency programs, and fund availability, utilizing peer or scientific review to select offerors. Successful projects are expected to follow a structure of base period tasks to demonstrate feasibility, followed by option tasks for design, fabrication, testing, and evaluation. Because the work supports DoD ISR-Cyber capabilities, offerors must possess the necessary personnel and facility security clearances to handle classified work independently. All acquired technologies are treated as commercial items under 10 USC 3458 and DFARS 212.70. Submissions are managed by Carissa Heuertz, and the performance location is identified as San Antonio, Texas.
Department Of Defense

POSTED

1 day ago

DEADLINE

in 11 months
View Details
NAICS: 325414
New
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposal issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an unrestricted, IDIQ contract focused on Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC). The scope of work includes the purchase and storage of VAC, the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract features a ceiling price of 800 million dollars and a long-term performance horizon, consisting of five one-year ordering periods for VAC and direct purchases starting December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The contractor is required to produce VAC with a minimum capacity of 1.0 million doses and maintain storage on their premises under strict quality control and temperature monitoring standards. Due to the nature of the material, live FMDV is classified as a Tier 1 Select Agent, requiring specific authorization from the CDC/APHIS and adherence to rigorous shipping and security restrictions. Award will be based on the most advantageous offer, evaluating technical capability, past performance, and price, with technical and past performance factors weighted equally. Proposals must be submitted electronically in four separate volumes by November 10, 2026.
Mrpbs Minneapolis Mn

POSTED

3 days ago

DEADLINE

in 12 days
View Details
NAICS: 541611
Federal
University Centers for Excellence in Developmental Disabilities Education, Research and Service Community Impact and Capacity Building Initiative: Technical Assistance to Strengthen Outcomes for People with I/DD and Their Families
Solicitation # UCEDD
The Department of Health and Human Services, through the Administration for Community Living and the Administration on Disabilities, has issued a Request for Information to conduct market research for a contract providing network-wide training, technical assistance, and capacity-building support to University Centers for Excellence in Developmental Disabilities Education, Research and Service. The primary objective is to strengthen outcomes for people with intellectual and developmental disabilities and their families in accordance with the Developmental Disabilities Assistance and Bill of Rights Act of 2000. The contemplated scope includes the development of Community Impact Blueprints to scale promising approaches, the creation of a Strategic TA Plan to establish annual levels of effort, and the implementation of technology solutions such as a Core Functions Dashboard and an AI-assisted chatbot. The government is seeking industry feedback on the feasibility of the draft Performance Work Statement, recommended staffing models, and rough order of magnitude cost estimates. Preliminary classification is under NAICS 541611 for Administrative Management and General Management Consulting Services. The anticipated contract structure consists of a base year and four option years, requiring strict adherence to HHS Information Security Program standards and Section 508 accessibility requirements. Interested respondents must submit their capabilities and recommendations by November 3, 2026.
Department Of Health And Human Services

POSTED

8 days ago

DEADLINE

in 5 days
View Details